貝康醫療-B(02170.HK):擬發行A股在科創板上市
格隆匯1月11日丨貝康醫療-B(02170.HK)宣佈,為了優化公司的資本結構,提升公司自我發展能力及實現公司戰略發展目標,董事會已決議就建議首次公開發售公司普通股並於上海證券交易所科創板以人民幣買賣("建議A股發售")展開相關籌備工作。
截至公吿日期,公司尚未制定建議A股發售的發售方案或釐定其架構,亦未向中華人民共和國或任何其他地區的任何相關監管機構申請批准建議A股發售,且建議A股發售須待(其中包括)董事會及股東正式批准以及中國證監會及其他相關監管機構批准後,方可作實。公司將於最終發售方案落實並獲董事會批准後根據公司章程的規定召開必要的股東大會及╱或類別大會,以供公司股東考慮並酌情批准建議A股發售。公司亦將遵守相關法律法規的所有適用規定(包括但不限於香港聯合交易所有限公司證券上市規則),並會於適當及╱或必要時候就建議A股發售的詳情、重大更新資料及發展情況另行刊發公吿。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.